SK Bioscience vaccine plant gets EU approval
Posted : 2021-05-17 14:59
By Kim Bo-eun
SK s vaccine contract manufacturer said Monday that it received quality approval from European authorities for its plant that produces COVID-19 vaccines here.
Its Andong plant in North Gyeongsang Province is manufacturㅑㅜㅎ COVID-19 vaccines for U.K. company AstraZeneca on a contract basis, and it plans to do so for U.S. firm Novavax, once drug authorities approve the vaccine.
SK Bioscience said that the European Medicines Agency determined its Andong plant met its good manufacturing practice (GMP) standards. GMP is the minimum standard Europe requires medicine manufacturers to meet in their production processes.
Novavax CEO to discuss vaccine supply with Moon koreatimes.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreatimes.co.kr Daily Mail and Mail on Sunday newspapers.